Tools & Resources

• Ovarian Cancer: An Overview
• Ovarian Cancer Gene?
• New Drug for Ovarian Cancer
• 15 Cancer Symptoms Women Ignore
• Dealing with Chemo Nausea
• Assess Your Cancer Risk

Medical ReferenceRelated to Ovarian Cancer

31. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - What is prevention?
    
    WebMD discusses methods of preventing ovarian cancer.
    
32. Ovarian Low Malignant Potential Tumors Treatment (PDQ®): Treatment - Patient Information [NCI] - About This PDQ Summary
    
    About PDQPhysician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in Spanish.PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government's center of biomedical research. The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.Purpose of This SummaryThis PDQ cancer information summary has current
    
33. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Treatment Option Overview
    
    There are different types of treatment for patients with ovarian germ cell tumors. Different types of treatment are available for patients with ovarian germ cell tumor. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.Four types of standard treatment are used: SurgerySurgery is the most common treatment of ovarian germ cell tumor. A doctor may take out the cancer using one of the following types of surgery. Unilateral salpingo-oophorectomy: A surgical procedure to remove one ovary and one fallopian
    
34. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Stages of Ovarian Low Malignant Potential Tumors
    
    After ovarian low malignant potential tumor has been diagnosed, tests are done to find out if abnormal cells have spread within the ovary or to other parts of the body.The process used to find out whether abnormal cells have spread within the ovary or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan treatment. Certain tests or procedures are used for staging. Staging laparotomy (a surgical incision made in the wall of the abdomen to remove ovarian tissue) may be used. Most patients are diagnosed with stage I disease. The following stages are used for ovarian low malignant potential tumor: Stage IIn stage I, the tumor is found in one or both ovaries. Stage I is divided into stage IA, stage IB, and stage IC. Stage IA: The tumor is found inside a single ovary.Stage IB: The tumor is found inside both ovaries.Stage IC: The tumor is found inside one or both
    
35. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Questions or Comments About This Summary
    
    If you have questions or comments about this summary, please send them to Cancer.gov through the Web site's Contact Form. We can respond only to email messages written in English.
    
36. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - To Learn More About Ovarian Epithelial Cancer
    
    For more information from the National Cancer Institute about ovarian epithelial cancer, see the following:Ovarian Cancer Home PageWhat You Need to Know About™ Ovarian CancerOvarian Cancer PreventionOvarian Cancer ScreeningUnusual Cancers of ChildhoodDrugs Approved for Ovarian CancerUnderstanding Cancer Series: Targeted Therapies (Advances in Targeted Therapies)Targeted Cancer TherapiesBRCA1 and BRCA2: Cancer Risk and Genetic TestingGenetic Testing for Hereditary Cancer SyndromesFor general cancer information and other resources from the National Cancer Institute, see the following:What You Need to Know About™ CancerUnderstanding Cancer Series: CancerCancer StagingChemotherapy and You: Support for People With CancerRadiation Therapy and You: Support for People With CancerCoping with Cancer: Supportive and Palliative CareQuestions to Ask Your Doctor About CancerCancer LibraryInformation For Survivors/Caregivers/Advocates
    
37. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Changes to This Summary (08 / 08 / 2013)
    
    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Changes were made to this summary to match those made to the health professional version.
    
38. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Stage III Ovarian Germ Cell Tumors
    
    DysgerminomasStandard treatment options:Total abdominal hysterectomy and bilateral salpingo-oophorectomy.Unilateral salpingo-oophorectomy with adjuvant chemotherapy.For patients with stage III dysgerminoma, total abdominal hysterectomy and bilateral salpingo-oophorectomy are recommended with removal of as much gross tumor as can be done safely without resection of portions of the urinary tract or large segments of the small or large bowel. Patients who want to preserve fertility may be treated with unilateral salpingo-oophorectomy if chemotherapy is to be employed.[1,2,3,4,5] (Refer to the PDQ summary on Sexuality and Reproductive Issues for more information on fertility.)Combination chemotherapy with bleomycin, etoposide, and cisplatin (BEP) can cure the majority of such patients. In a report of results from two Gynecologic Oncology Group (GOG) trials, 19 of 20 patients with incompletely resected tumors who were treated with BEP or cisplatin, vinblastine, and bleomycin (PVB) were
    
39. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - To Learn More About Ovarian Germ Cell Tumors
    
    For more information from the National Cancer Institute about ovarian germ cell tumors, see the following:Ovarian Cancer Home PageDrugs Approved for Ovarian CancerFor general cancer information and other resources from the National Cancer Institute, see the following:What You Need to Know About™ CancerUnderstanding Cancer Series: CancerCancer StagingChemotherapy and You: Support for People With CancerRadiation Therapy and You: Support for People With CancerCoping with Cancer: Supportive and Palliative CareQuestions to Ask Your Doctor About CancerCancer LibraryInformation For Survivors/Caregivers/Advocates
    
40. Ovarian Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Get More Information From NCI
    
    Call 1-800-4-CANCERFor more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.Chat online The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer. Write to usFor more information from the NCI, please write to this address:NCI Public Inquiries Office9609 Medical Center Dr. Room 2E532 MSC 9760Bethesda, MD 20892-9760Search the NCI Web siteThe NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support